75 results
DEFA14A
ALGS
Aligos Therapeutics Inc
29 Apr 24
Additional proxy soliciting materials
4:04pm
; 1.01 Lawrence M. Blatt, Ph.D
1.02 James Scopa
2. The ratification of the appointment, by the Audit Committee of our board of directors, of Ernst
PRE 14A
ubpk9sbpaocagto
16 Apr 24
Preliminary proxy
5:27pm
424B3
zqi6g
28 Nov 23
Prospectus supplement
4:01pm
8-K
EX-10.1
tt5pp66qmb45 nrgg
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
yl7mv g4n3n
25 Jul 23
Submission of Matters to a Vote of Security Holders
4:02pm